AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States.
The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance.
The company was incorporated in 2017 and is based in Fort Myers, Florida.
Country | United States |
IPO Date | May 5, 2021 |
Industry | Medical - Care Facilities |
Sector | Healthcare |
Employees | 1,525 |
CEO | Todd Schonherz |
Contact Details
Address: 14543 Global Parkway Fort Myers, Florida United States | |
Website | https://www.aoncology.com |
Stock Details
Ticker Symbol | AONC |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001839998 |
CUSIP Number | 028719102 |
ISIN Number | US0287191029 |
Employer ID | 00-0000000 |
SIC Code | 6770 |
Key Executives
Name | Position |
---|---|
Todd Schonherz | Chief Executive Officer & Director |
David Afshar CPA | Principal Accounting Officer, Chief Financial Officer & Chief Operating Officer |
Mark Moch | Chief Information Officer |
Caroline Hewitt | Vice President of Marketing |
Dr. Stephen Divers M.D. | Chief Medical Officer, VC of Board of Managers & Chairman of Advisory Board Executive Committee |
Erica Mallon | General Counsel |
James Gilmore Pharm.D. | Chief Pharmacy & Clinical Services Officer |
Karen Pilley | Chief Revenue Cycle Officer |
Karen Quick | Vice President of Human Resources |
Kristin Matisziw | Chief Compliance & Risk Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 02, 2025 | 15-15D | Filing |
Dec 26, 2024 | 8-K/A | [Amend] Current Report |
Dec 19, 2024 | 8-K | Current Report |
Dec 18, 2024 | 8-K | Current Report |
Dec 12, 2024 | S-8 POS | Filing |
Dec 12, 2024 | POS AM | Filing |
Nov 15, 2024 | 424B3 | Filing |
Nov 13, 2024 | 10-Q | Quarterly Report |
Aug 15, 2024 | 424B3 | Filing |
Aug 14, 2024 | 10-Q | Quarterly Report |